Related Experiment Video

Updated: Oct 2, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K

[Development and progress in respiratory tract infections]

Mathias W Pletz1

  • 1Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena/Friedrich Schiller Universität Jena, 07740 Jena, Deutschland.

Der Pneumologe
|February 23, 2022
PubMed

Insights

Infectious diseases remain a global threat, necessitating advancements in treating multidrug-resistant pathogens and airway infections. Innovations like pathogen sequencing, AI, and new vaccines are improving patient outcomes and infection management.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology
  • Vaccinology

Context:

  • Global infectious diseases, including multidrug-resistant pathogens and viral/bacterial airway infections, pose significant threats despite medical advancements.
  • The COVID-19 pandemic highlighted the importance of understanding airway infections and the role of immunomodulation.
  • Carbapenem-resistant Enterobacteriaceae (CRE) present a growing therapeutic challenge in nosocomial pneumonia.

Purpose:

  • To provide an overview of recent significant innovations in the field of airway infections.
  • To highlight advancements in diagnostics, therapeutics, and preventative strategies for managing infectious diseases.

Summary:

  • Recent innovations include pathogen sequencing, point-of-care testing, and artificial intelligence for improved airway infection management.
  • New beta-lactam antibiotics effective against CRE offer therapeutic options, though resistance mechanisms impact efficacy.
  • Vaccine advancements include an extended 20-valent pneumococcal conjugate vaccine for adults and a high-dose influenza vaccine for older adults.

Impact:

  • These innovations are expected to enhance the diagnosis, treatment, and prevention of airway infections and other infectious diseases.
  • Improved management strategies will help combat the threat of multidrug-resistant pathogens and reduce the burden of nosocomial infections.
  • Advances in vaccines and therapeutics contribute to better public health outcomes and preparedness for future infectious disease outbreaks.
Keywords:
COVID-19ImmunomodulationNosocomial pneumoniaResistanceVaccine

More Related Videos

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip06:11

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

Published on: March 29, 2024

2.0K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

553

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
977
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
482
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
377
Physical Assessment of the Respiratory Tract I: Health History01:28

Physical Assessment of the Respiratory Tract I: Health History

Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
437
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
509
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
225